Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia

Inclusion Criteria: * Presbyopic male or female 40-55 years of age * Willing and able to provide written informed consent on the IRB/IEC approved informed consent form Exclusion Criteria: * Sensitivity or known allergy to pilocarpine or any of the other excipients of the formulation * History of eczema, dermatitis or skin sensitivity to over-the-counter personal care products * History of, or active, iritis or uveitis in either eye * Pre-existing retinal diseases in either eye that may pre-dispose the subjects to retinal detachment